Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study

Booster doses of meningococcal conjugate vaccines induce long-term protection against invasive meningococcal disease. We evaluated the immunogenicity and safety of a booster dose of MenACYW-TT in pre-school children who were primed 3 years earlier with MenACYW-TT or MCV4-TT (Nimenrix®). In this Phas...

Descripción completa

Detalles Bibliográficos
Autores principales: Piazza, Franco M., Virta, Miia, Paassilta, Marita, Ukkonen, Benita, Ahonen, Anitta, Esteves-Jaramillo, Alejandra, Forsten, Aino, Seppa, Ilkka, Ding, Jian, Neveu, David, Jordanov, Emilia, Dhingra, Mandeep S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Meningococcal – Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920225/
https://www.ncbi.nlm.nih.gov/pubmed/34085900
http://dx.doi.org/10.1080/21645515.2021.1902701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920225/
https://www.ncbi.nlm.nih.gov/pubmed/34085900
http://dx.doi.org/10.1080/21645515.2021.1902701

Ejemplares similares